Assessment and State of Nutrition of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms

Assessment and State of Nutrition of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms

Introduction: In recent decades, the number of gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) cases, associated with coexisting metabolic disorders, has been continuously increasing. Patients with progressing neoplastic disease are at a risk of malnutrition. To improve the quality of l...

Full description

Bibliographic Details
Main Authors:	Justyna Kikut, Anna Jasińska, Jakub Pobłocki, Jacek Brodowski, Szczuko Małgorzata
Format:	Article
Language:	English
Published:	MDPI AG 2020-06-01
Series:	Nutrients
Subjects:	neuroendocrine neoplasms gastroenteropancreatic neuroendocrine neoplasms nutrition methods of nutrition nutritional status
Online Access:	https://www.mdpi.com/2072-6643/12/7/1961

Similar Items

The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition
by: Jakub Pobłocki, et al.
Published: (2020-05-01)

Research Progress of Gastroenteropancreatic Neuroendocrine Neoplasm
by: LUO Wenhao, et al.
Published: (2018-01-01)

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors
by: Paragliola RM, et al.
Published: (2016-10-01)

Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China
by: Cheng Fang, et al.
Published: (2017-06-01)

Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm
by: Yuhong Wang, et al.
Published: (2018-06-01)

A NEW INCOME IN PEDIATRIC PATHOLOGY: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS. PART I: PANCREATIC TUMORS
by: Smaranda DIACONESCU, et al.
Published: (2013-03-01)

Myeloid and T-Cell Microenvironment Immune Features Identify Two Prognostic Sub-Groups in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms
by: Giovanni Centonze, et al.
Published: (2021-04-01)

Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendocrine neoplasms: A single-institution analysis (1995–2012) in South China
by: Wang Yu-hong, et al.
Published: (2012-11-01)

Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study
by: Huiying Shi, et al.
Published: (2018-07-01)

Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine‐non‐neuroendocrine neoplasm
by: Panpan Zhang, et al.
Published: (2021-07-01)

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness
by: Luigi Barrea, et al.
Published: (2018-12-01)

P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms
by: Kirstine Nielsen, et al.
Published: (2020-01-01)

Clinicopathologic Features of Gastroenteropancreatic Neuroendocrine Tumors: A Single-center Experience
by: Tuğba Akın Telli, et al.
Published: (2020-09-01)

Role of endoscopic submucosal dissection in treatment of rectal gastroenteropancreatic neuroendocrine neoplasms
by: Michał Spychalski, et al.
Published: (2016-12-01)

Liver metastases in gastroenteropancreatic neuroendocrine tumours – treatment methods
by: Paweł Gut
Published: (2020-01-01)

Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm
by: Huiying Shi, et al.
Published: (2020-09-01)

First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
by: Bongiovanni A, et al.
Published: (2015-12-01)

LAT-1 and GLUT-1 Carrier Expression and Its Prognostic Value in Gastroenteropancreatic Neuroendocrine Tumors
by: Miguel Sampedro-Núñez, et al.
Published: (2020-10-01)

Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors
by: Mauro Cives, et al.
Published: (2020-11-01)

Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors
by: Andrea Sansone, et al.
Published: (2019-08-01)

Satisfaction and quality of life in patients with symptomatic gastroenteropancreatic neuroendocrine tumours treated with lanreotide Autogel in South Africa
by: Daleen Geldenhuys, et al.
Published: (2020-10-01)

Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases
by: Bruna Estrozi, et al.
Published: (2011-01-01)

Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review
by: Baptiste Camus, et al.
Published: (2021-03-01)

Recurrent Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm in the Gallbladder: A Case Report
by: Turki Al-Fayea, et al.
Published: (2021-03-01)

Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study
by: Meng Zhang, et al.
Published: (2017-07-01)

Patient And Nurse Experience Of Using Somatostatin Analogues To Treat Gastroenteropancreatic Neuroendocrine Tumors: Results Of The Somatostatin Treatment Experience Trial (STREET)
by: Ström T, et al.
Published: (2019-10-01)

Visceral Obesity and Metabolic Syndrome Are Associated with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
by: Ana P. Santos, et al.
Published: (2018-08-01)

Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide
by: Beata Kos-Kudła, et al.
Published: (2017-06-01)

Lutetium oxodotreotide (177Lu-Dotatate) for the treatment of unresectable or metastatic progressive gastroenteropancreatic neuroendocrine tumors: a cost-effectiveness analysis for Scotland
by: J. Smith-Palmer, et al.
Published: (2021-01-01)

Review article: Histopathology of gastrointestinal neuroendocrine neoplasms
by: Kenichi eHirabayashi, et al.
Published: (2013-01-01)

Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients
by: Kiwoon Baeg, et al.
Published: (2021-02-01)

Natural History of Renal Neuroendocrine Neoplasms: A NET by Any Other Name?
by: Andrew H. Nguyen, et al.
Published: (2021-02-01)

Gastric Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Western Center Case Series
by: Marcus Fernando Kodama Pertille Ramos, et al.
Published: (2021-06-01)

Treatment with Lanreotide Depot Following Octreotide Long-Acting Release Among Patients with Gastroenteropancreatic Neuroendocrine Tumors
by: Muhammad Wasif Saif, et al.
Published: (2018-10-01)

Incidence and Survival Outcomes in Patients with Lung Neuroendocrine Neoplasms in the United States
by: Shrunjal Shah, et al.
Published: (2021-04-01)

Imaging presentation of pancreatic neuroendocrine neoplasms
by: Valentina Ciaravino, et al.
Published: (2018-10-01)

Symptoms and Quality of Life in Gastroenteropancreatic Neuroendocrine Tumours
by: Rajaventhan Srirajaskanthan, et al.
Published: (2014-03-01)

PD-L1 Expression and Immune Cell Infiltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative Activity
by: Martina Ferrata, et al.
Published: (2019-05-01)

Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection
by: Yang Lv, et al.
Published: (2019-04-01)

MiRNA Expression in Neuroendocrine Neoplasms of Frequent Localizations
by: Alexandra Korotaeva, et al.
Published: (2021-06-01)